Tianjin TEDA Biomedical Engineering Company Limited

HK$0.13As of Sun 8 Nov 2026, 12:00 UTC
HKEX:8189Materials
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (16.48%)
Div yield —
ROE (140.82%)
Agricultural Inputs
Beta (5Y) (0.20)
PE TTM —
TSR TTM (66.67%)
Mkt cap HK$277.4M
ROIC (54.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.141
8.33%
(92.95%)
Hold 9|11|1|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
—
—
—
—
11.03%
20.12%
16.22%
16.06%
Revenue¥M
15.68
16.40
16.65
17.09
4.45%
7.15%
10.63%
10.61%
Peers (US$35.39M)
Cap (US$)
PE
37.12M
—
Capital
TTM
5Y
10Y
Leveragex
0.187
0.080
0.053
EBIT/Intx
0.452
0.662
0.671
Own earn%
(50.03)
12.89
31.48
Sh yield%
16.65
21.71
24.20
Owners
Insiders/Inst%
14.75
48.37
Short interest%
2.46
SBC / revenue%
4.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
10–21
$1 testx
—
Incr. ROIC%
11